Europe Pen Needles Market worth $1.10 billion by 2031
The report "Europe Pen Needles Market By Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-like Peptide-1 Therapy), Mode of Purchase (Over-the-counter Purchase, Online Purchase) - Forecast to 2031" The Europe pen needles market is projected to reach USD 1.10 billion by 2031 from USD 0.72 billion in 2026 at a CAGR of 8.9% during the forecast period.
Browse 150 market data Tables and 80 Figures spread through 200 Pages and in-depth TOC on "Europe Pen Needles Market By Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-like Peptide-1 Therapy), Mode of Purchase (Over-the-counter Purchase, Online Purchase) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-pen-needles-market-159977651.html
The government supports programs that promote the adoption of pen needles across Europe, leading to better access to essential diabetes management tools. An example of this benefit is reimbursement or partial coverage for the cost of insulin pens and pen needles in several countries, which eases the financial burden on patients while encouraging treatment adherence. Health systems have also launched national awareness and educational campaigns emphasizing the importance of proper insulin administration and regular monitoring. All these initiatives aim to improve patient compliance, reduce long-term treatment complications, and increase the use of pen needles throughout the region, thereby enhancing the overall quality of diabetes care.
This report categorizes the pen needles market based on type, length, application, mode of purchase, setting, and region.
The standard pen needles segment accounted for the largest share of the Europe pen needles market in 2025.
To support initiatives encouraging the use of pen needles in Europe, governments are working to improve access to essential diabetes management tools. One approach involves reimbursing or partially covering the costs of insulin pens and pen needles in various countries, thereby reducing the financial burden on patients and ultimately improving treatment adherence. Health systems have initiated national programs, launching awareness and education campaigns on the importance of administering insulin properly and monitoring it regularly. These efforts aim to boost patient compliance and reduce long-term complications, ultimately increasing the use of pen needles across the region. This is a positive sign for the overall quality of diabetes care in the area.
The online purchase segment is expected to grow at the highest CAGR during the forecast period of the Europe pen needles market.
The segment about online purchases is likely to experience the highest growth rate in the pen needles market in Europe, due to increasing popularity of e-commerce in healthcare, greater convenience for patients, and better access for those with mobility issues or living in remote areas. Online platforms provide competitive prices, subscription options, discreet delivery, and a broader product selection compared to local pharmacies. Rising digital health literacy and expanding pharmacy e-commerce networks, along with supportive regulations, have further sped up the market shift toward online purchases of pen needles.
France is expected to exhibit the highest growth rate during the forecast period.
While other European countries aim to boost their growth, France seems to be best positioned for this due to its strong national diabetes program, increased reimbursement for insulin delivery devices, and growing acceptance of injectable insulin and GLP-1 therapies. The rising prevalence of diabetes in the country contributes to the steady demand for pen-based injection systems. An increasingly sophisticated e-pharmacy infrastructure in France and growing acceptance of medical online purchases can also further boost the market growth. In this regard, the government’s focus on safety in clinical settings accelerates the adoption of safety pen needles. Combined with patient education programs and better healthcare access, these factors make France highly favorable for market growth.
Key Market Players:
Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B. Braun SE (Germany), Owen Mumford (UK), Terumo Corporation (Japan), NIPRO Corporation (Japan), Allison Medical, Inc. (US), AdvaCare Pharma (US), Berpu Medical Technology Co., Ltd. (China), GlucoRx Limited (UK), HTL-STREFA (Poland), UltiMed, Inc. (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), VOGT Medical Vertrieb GmbH (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), IYON Medical (Turkey), Links Medical Products, Inc. (US), and MHC Medical Products, LLC (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Pen Needles Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
